These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26342005)

  • 1. Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria.
    Clifford-Mobley O; Hewitt L; Rumsby G
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):485-94. PubMed ID: 26342005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria.
    Woodward G; Pryke R; Hoppe B; Rumsby G
    Ann Clin Biochem; 2019 Mar; 56(2):232-239. PubMed ID: 30373392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
    Fang X; He L; Xu G; Lin H; Xu M; Geng H
    Pediatr Nephrol; 2019 Oct; 34(10):1785-1790. PubMed ID: 31123811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
    Fargue S; Milliner DS; Knight J; Olson JB; Lowther WT; Holmes RP
    J Am Soc Nephrol; 2018 Jun; 29(6):1615-1623. PubMed ID: 29588429
    [No Abstract]   [Full Text] [Related]  

  • 5. Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.
    Dietzen DJ; Wilhite TR; Kenagy DN; Milliner DS; Smith CH; Landt M
    Clin Chem; 1997 Aug; 43(8 Pt 1):1315-20. PubMed ID: 9267307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late diagnosis of primary hyperoxaluria type III.
    Richard E; Blouin JM; Harambat J; Llanas B; Bouchet S; Acquaviva C; de la Faille R
    Ann Clin Biochem; 2017 May; 54(3):406-411. PubMed ID: 27742850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.
    Ventzke A; Feldkötter M; Wei A; Becker J; Beck BB; Hoppe B
    Pediatr Nephrol; 2017 Dec; 32(12):2263-2271. PubMed ID: 28711958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function can be impaired in children with primary hyperoxaluria type 3.
    Allard L; Cochat P; Leclerc AL; Cachat F; Fichtner C; De Souza VC; Garcia CD; Camoin-Schweitzer MC; Macher MA; Acquaviva-Bourdain C; Bacchetta J
    Pediatr Nephrol; 2015 Oct; 30(10):1807-13. PubMed ID: 25972204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.
    Singh P; Viehman JK; Mehta RA; Cogal AG; Hasadsri L; Oglesbee D; Olson JB; Seide BM; Sas DJ; Harris PC; Lieske JC; Milliner DS
    Nephrol Dial Transplant; 2022 Apr; 37(5):869-875. PubMed ID: 33543760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
    Belostotsky R; Pitt JJ; Frishberg Y
    J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
    Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
    BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
    Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.
    Shen Y; Luo X; Li H; Guan Q; Cheng L
    J Clin Lab Anal; 2021 Aug; 35(8):e23870. PubMed ID: 34097312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hyperoxaluria type 2.
    Mansell MA
    Nephrol Dial Transplant; 1995; 10 Suppl 8():58-60. PubMed ID: 8592629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite diagnosis of primary hyperoxaluria type 3.
    Greed L; Willis F; Johnstone L; Teo S; Belostotsky R; Frishberg Y; Pitt J
    Pediatr Nephrol; 2018 Aug; 33(8):1443-1446. PubMed ID: 29705963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1.
    Boehm T; Martin-Higueras C; Friesser E; Zitta C; Wallner S; Walli A; Kovacevic K; Hubmann H; Klavins K; Macheroux P; Hoppe B; Jilma B
    Urolithiasis; 2023 Mar; 51(1):49. PubMed ID: 36920530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of primary hyperoxaluria type 2 (L-glyceric aciduria) in patients with maintained renal function or end-stage renal failure.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Cadario A; Barbos MP; Gurioli L; Linari F
    Nephrol Dial Transplant; 1995; 10(8):1381-5. PubMed ID: 8538930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
    van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
    Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Still diagnosed too late and under-recognized? The first comprehensive report on primary hyperoxaluria in Poland.
    Sikora P; Zaniew M; Grenda R; Jobs K; Rubik J; Zawadzki J; Myślak M; Durlik M; Erger F; Bieniaś B; Hoppe B; Beck BB
    Pol Arch Intern Med; 2020 Dec; 130(12):1053-1063. PubMed ID: 33274618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
    Riedel TJ; Knight J; Murray MS; Milliner DS; Holmes RP; Lowther WT
    Biochim Biophys Acta; 2012 Oct; 1822(10):1544-52. PubMed ID: 22771891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.